Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnWeb3SquareMore
Trade
Spot
Buy and sell crypto with ease
Margin
Amplify your capital and maximize fund efficiency
Onchain
Going Onchain, without going Onchain!
Convert & block trade
Convert crypto with one click and zero fees
Explore
Launchhub
Gain the edge early and start winning
Copy
Copy elite trader with one click
Bots
Simple, fast, and reliable AI trading bot
Trade
USDT-M Futures
Futures settled in USDT
USDC-M Futures
Futures settled in USDC
Coin-M Futures
Futures settled in cryptocurrencies
Explore
Futures guide
A beginner-to-advanced journey in futures trading
Futures promotions
Generous rewards await
Overview
A variety of products to grow your assets
Simple Earn
Deposit and withdraw anytime to earn flexible returns with zero risk
On-chain Earn
Earn profits daily without risking principal
Structured Earn
Robust financial innovation to navigate market swings
VIP and Wealth Management
Premium services for smart wealth management
Loans
Flexible borrowing with high fund security
"Exonerated after 43 years, now deportation over 1983 drug plea"

"Exonerated after 43 years, now deportation over 1983 drug plea"

Bitget-RWA2025/10/29 19:10
By:Bitget-RWA

- Subu Vedam, exonerated after 43 years in prison for a murder conviction, now faces deportation over a 1983 drug plea. - His lawyers argue decades of wrongful imprisonment qualify him for immigration waivers under U.S. law. - DHS contends Vedam failed to promptly address his immigration status, rejecting claims of exceptional hardship. - The case highlights tensions in Trump-era immigration enforcement and the intersection of criminal justice errors with deportation policies.

Subramanyam "Subu" Vedam, who spent 43 years incarcerated in Pennsylvania for a murder conviction that was ultimately overturned, now faces the threat of deportation after a 1999 removal order resurfaced following his release in August 2025. Vedam, 64, who came to the United States from India as a baby, was taken into custody by U.S. Immigration and Customs Enforcement (ICE) on October 3, 2025, just days after a judge threw out his murder conviction based on new ballistics evidence,

. His situation has become a focal point in the Trump administration’s intensified immigration enforcement efforts, with supporters contending that his decades-long wrongful imprisonment should outweigh a previous drug offense, .

Vedam’s legal challenges began in 1980 when he was accused of killing his friend Thomas Kinser, a fellow student at Penn State. Despite the absence of witnesses or a clear motive, Vedam was convicted twice, the last time in 1988, NBC News stated. His defense team later uncovered an FBI document showing the fatal bullet did not match the .25-caliber firearm Vedam had bought, a fact prosecutors withheld, ABC News noted. After a review in 2023, Centre County Judge David Stockinger overturned the conviction, and prosecutors opted not to pursue a new trial, NBC News reported.

Yet, Vedam’s reprieve was brief. Federal immigration officials pointed to a 1999 deportation order linked to a drug conviction—he had pleaded no contest to selling LSD in 1983—as grounds for his detention, NBC News said. Vedam’s attorney, Ava Benach, argues that the extraordinary injustice he endured should make him eligible for relief under immigration law. “Spending forty-three years wrongfully imprisoned more than compensates for a drug offense committed at age 20,” she told ABC News.

The Department of Homeland Security, however, maintains that Vedam did not act quickly enough to protect his immigration status. Assistant chief counsel Katherine Frisch wrote in a brief that “he has not provided any evidence or arguments demonstrating diligence in pursuing his immigration rights,” NBC News reported. ICE has resisted reopening his case, maintaining that “the deadline passed years ago,” according to ABC News.

Supporters of Vedam emphasize the positive changes he made while incarcerated. He obtained several academic degrees, tutored other prisoners, and maintained an exemplary record except for a minor incident involving rice, NBC News reported. His sister, Saraswathi Vedam, a midwifery professor in Vancouver, described him as “patient” in the face of adversity. “He understands better than anyone that sometimes life is illogical. You just have to persist and trust that truth, justice, compassion, and kindness will ultimately prevail,” she told ABC News.

This case highlights ongoing debates over U.S. immigration policy, especially under the Trump administration’s focus on deportation. While Vedam’s legal team seeks a hearing before the Board of Immigration Appeals, his future remains uncertain. For now, he is being held at an ICE facility in central Pennsylvania, awaiting a decision that will shape what comes next, NBC News reported.

0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

PoolX: Earn new token airdrops
Lock your assets and earn 10%+ APR
Lock now!

You may also like

Institutional integration and practical applications drive the rise of HBAR, AVAX, and BDAG altcoins

- Hedera's HBAR gains 7% on Nasdaq ETF debut, becoming third crypto ETF after Bitcoin and Ethereum, signaling institutional confidence. - Avalanche's AVAX secures $638M in tokenized Treasurys and attracts Wyoming's FRNT stablecoin, but struggles with $19.66 price amid market volatility. - BlockDAG (BDAG) raises $432M pre-launch with 312K+ holders, positioning as potential 2025 breakout via $0.05 listing target and live Layer-1 network. - Market shifts toward utility-driven altcoins like HBAR's AI governanc

Bitget-RWA2025/10/31 04:38
Institutional integration and practical applications drive the rise of HBAR, AVAX, and BDAG altcoins

Bitcoin News Update: Hong Kong Cautions That DAT Premiums May Disappear Suddenly, Triggering a Wave of Selling

- DAT strategy stocks like MSTR and meme DATs face sharp sell-offs, with MSTR down 53% and major meme DATs losing over 80% as investor confidence wanes. - Hong Kong regulators warn DAT premiums (e.g., mNAV ratios) could vanish rapidly under stricter oversight, citing MSTR's 3.6% YTD share decline despite Bitcoin gains. - U.S. crypto ETFs lost $552M in two days (Oct 29-30), with Fidelity's FBTC leading outflows, as Fed Chair Powell hinted 2025 rate cuts may end, deepening market uncertainty. - Bitcoin and E

Bitget-RWA2025/10/31 04:38
Bitcoin News Update: Hong Kong Cautions That DAT Premiums May Disappear Suddenly, Triggering a Wave of Selling

Dogecoin News Today: Meme Coin Joins Forces with Defense: Former Air Force Leader Commits $53M to Dogecoin

- A U.S. Air Force commander invested $53M in Dogecoin, signaling growing institutional confidence in the meme coin despite its volatility. - Recent whale activity and a 20% surge in DOGE trading volume highlight increased market speculation and liquidity. - The Dogecoin Treasury's planned public listing could attract institutional investors, potentially stabilizing its price amid regulatory risks. - XRP's 7% weekly gain reflects broader crypto optimism, though technical indicators caution short-term trade

Bitget-RWA2025/10/31 04:38
Dogecoin News Today: Meme Coin Joins Forces with Defense: Former Air Force Leader Commits $53M to Dogecoin

Bitcoin News Update: MicroStrategy's Bold Crypto Bet Falters as Shares Plunge 53% Due to Investor Skepticism

- MicroStrategy's stock plunged 53% as Bitcoin's 8% drop eroded $18B in market cap, linking its fate to crypto volatility. - The company's Bitcoin-centric strategy faces skepticism despite $74B in BTC holdings, with critics warning of unproven risk. - Macroeconomic headwinds, Fed policy uncertainty, and regulatory pressures amplified the selloff in crypto-linked equities. - Analysts split between bearish technical indicators and bullish S&P 500 inclusion potential, while CEO Phong Le maintains $150K BTC pr

Bitget-RWA2025/10/31 04:18
Bitcoin News Update: MicroStrategy's Bold Crypto Bet Falters as Shares Plunge 53% Due to Investor Skepticism